What is CorMedix's total?

CorMedix (CRMD) reported total of $8.5M in Q4 2025.

How has CorMedix's total changed year-over-year?

CorMedix's total decreased by 75.1% year-over-year, from $34.16M to $8.5M.

What is the long-term trend for CorMedix's total?

Over 3 years (2022 to 2025), CorMedix's total has grown at a -28.2% compound annual growth rate (CAGR), from $22.96M to $8.5M.

CorMedix CRMD Total

Total at other companies

Merck & Co.MRK

——

Mirum Pharmaceuticals, Inc.MIRM

——

Zevra Therapeutics, Inc.ZVRA

——

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's total?: CorMedix (CRMD) reported total of $8.5M in Q4 2025.
How has CorMedix's total changed year-over-year?: CorMedix's total decreased by 75.1% year-over-year, from $34.16M to $8.5M.
What is the long-term trend for CorMedix's total?: Over 3 years (2022 to 2025), CorMedix's total has grown at a -28.2% compound annual growth rate (CAGR), from $22.96M to $8.5M.